Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Brain Neoplasms 22 Carcinoma, Non-Small-Cell Lung 17 Pancreatic Neoplasms 11 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 9 Glioblastoma 8 Breast Neoplasms 8 Carcinoma, Hepatocellular 7 Squamous Cell Carcinoma of Head and Neck 6 Glioma 6 Carcinoma, Renal Cell 6 Neoplasms 5 Colorectal Neoplasms 5 Head and Neck Neoplasms 4 Uveal Melanoma 3 Oligodendroglioma 3 Liver Neoplasms 3 Gliosarcoma 3 Astrocytoma 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2

Interventions

Cisplatin 11 Pemetrexed 10 pembrolizumab 9 Nivolumab 3 LMB-100 3 budigalimab 2 belinostat 2 amatuximab 2 Paclitaxel 2 Docetaxel 2 Dexamethasone 2 Cyclophosphamide 2 Carboplatin 2 Calcium Dobesilate 2 venetoclax 1 trametinib 1 tislelizumab 1 tazemetostat 1 talazoparib 1 spartalizumab 1 sodium thiosulfate 1 sargramostim 1 ruxolitinib 1 rovalpituzumab tesirine 1 olaparib 1 obinutuzumab 1 naptumomab estafenatox 1 irinotecan sucrosofate 1 fludarabine 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Mesothelioma × Radiosurgery × Clear all

NCT04166734 2026-02-04

MESO-PRIME

Royal Marsden NHS Foundation Trust

Phase 1 Terminated

5 enrolled 13 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡